Among these, Méplan and colleagues (2010) first reported that genetic variants known to affect the functional activity of selenoproteins in the GPX4, SELENOP, and SELENOS genes were associated with CRC risk in a case–control study from the Czech Republic [11], a European country of known low Se status [17]. The gene discussed is SELENOP; the disease is colorectal carcinoma.